Redsense Medical AB (publ) (RDSNF)

Redsense Medical AB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2024	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10	11	11	13	38	76
Market Cap Growth	-0.57%	-0.57%	-16.90%	-66.57%	-50.02%	321.86%
Enterprise Value	9	9	10	11	35	76
Last Close Price	0.51	0.51	1.05	-	-	-
PE Ratio	327.17	341.40	-	-	-	-
PS Ratio	3.89	4.06	4.18	7.95	21.13	36.70
PB Ratio	2.83	2.95	4.62	4.90	9.21	8.57
P/TBV Ratio	2.83	2.95	4.62	4.90	9.21	8.57
EV/Sales Ratio	2.87	3.50	3.91	7.10	19.50	36.43
EV/EBITDA Ratio	16.33	19.90	-	-	-	-
EV/EBIT Ratio	-	481.77	-	-	-	-
Debt / Equity Ratio	-	-	-	-	0.07	-
Asset Turnover	0.84	0.84	0.89	0.45	0.27	0.35
Inventory Turnover	2.91	2.91	8.57	3.78	3.20	4.79
Quick Ratio	9.79	9.79	3.26	4.42	9.78	12.35
Current Ratio	12.66	12.66	3.88	5.03	10.34	12.85
Return on Equity (ROE)	1.09%	1.09%	-17.96%	-27.10%	-14.40%	-20.50%
Return on Assets (ROA)	0.38%	0.38%	-11.00%	-17.25%	-12.29%	-10.39%
Return on Capital (ROIC)	0.42%	0.42%	-12.53%	-18.98%	-13.23%	-11.36%
Return on Capital Employed (ROCE)	0.50%	0.50%	-	-	-	-
Earnings Yield	0.31%	0.29%	-4.23%	-6.58%	-2.31%	-1.44%
FCF Yield	-7.37%	-7.06%	-4.78%	-7.39%	-3.64%	-1.06%
Buyback Yield / Dilution	-21.25%	-21.25%	0.16%	-0.60%	-	-15.33%
Total Shareholder Return	-21.25%	-21.25%	0.16%	-0.60%	-	-15.33%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.